SavedAdd your journal

Journals / Turkish Journal of Medical Sciences / 2013 / Cilt: 43 - Sayı: 3

The role of vitamin D deficiency in parathyroid hormone levels

Alpaslan KILIÇARSLAN
Alma CENOLİ ASLAN
Gamze GEZGEN
Pages
368–372
Publication Date
2013-03-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: It was found that 22.3% of the patients had high levels of PTH and 92% of them had secondary hyperparathyroidism.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Vitamin D deficiency is an important cause of secondary hyperparathyroidism.
📊
Key Findings & Data:Materials and methods: We retrospectively chose 2226 patients who were admitted to our hospital’s general internal medicine department for various reasons and had both PTH and vitamin D tests on the same day.
💡
Conclusion & Impact:Results: It was found that 22.3% of the patients had high levels of PTH and 92% of them had secondary hyperparathyroidism.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Key words: Vitamin D deficiency · high parathyroid hormone levels · secondary hyperparathyroidism

Abstract

Vitamin D deficiency is an important cause of secondary hyperparathyroidism. We aimed to investigate the effect of vitamin D levels on parathyroid hormone (PTH) levels. Materials and methods: We retrospectively chose 2226 patients who were admitted to our hospital’s general internal medicine department for various reasons and had both PTH and vitamin D tests on the same day. Results: It was found that 22.3% of the patients had high levels of PTH and 92% of them had secondary hyperparathyroidism. The average vitamin D level was 16.4 ng/mL. The vitamin D levels of 64% of the patients were below 20 ng/mL (n = 1417), and those of the rest of the patients were above 20 ng/mL (n = 809). Of the patients with vitamin D deficiency (

Özet

Vitamin D deficiency is an important cause of secondary hyperparathyroidism. We aimed to investigate the effect of vitamin D levels on parathyroid hormone (PTH) levels. Materials and methods: We retrospectively chose 2226 patients who were admitted to our hospital’s general internal medicine department for various reasons and had both PTH and vitamin D tests on the same day. Results: It was found that 22.3% of the patients had high levels of PTH and 92% of them had secondary hyperparathyroidism. The average vitamin D level was 16.4 ng/mL. The vitamin D levels of 64% of the patients were below 20 ng/mL (n = 1417), and those of the rest of the patients were above 20 ng/mL (n = 809). Of the patients with vitamin D deficiency (

🔖

Cite This Article

KILIÇARSLAN, A., ASLAN, A. C., GEZGEN, G. (2013). The role of vitamin D deficiency in parathyroid hormone levels. Turkish Journal of Medical Sciences, Cilt: 43 - Sayı: 3, 368–372. https://ajindex.com/articles/406580

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. McCabe MP, Smyth MP, Richardson DR. Current concept review: vitamin D and stress fractures. Foot Ankle Int 2012; 33: 526–33. 6. Mehrdad S, Samane T, Zahra N. The optimal dose of vitamin D in growing girls during academic years: a randomized trial. Turk J Med Sci 2011; 41: 33–37. 7. Bischoff-Ferrari H. Vitamin D: What is an adequate vitamin D level and how much supplementation is necessary? Best Pract Res Clin Rheumatol 2009; 23: 789–95. 8. Malabanan A, Veronikis IE, Holick MF. Redefining vitamin D insufficiency. Lancet 1998; 351: 805–6. 9. Chapuy MC, Preziosi P, Maamer M, Arnaud S, Galan P, Hercberg S et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporosis Int 1997; 7: 439–43. Holick MF. Vitamin D deficiency: what a pain it is. Mayo Clin Proc 2003; 78: 1457–59.
  2. Plotnikoff GA, Quigley JM. Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin Proc 2003; 78: 1463–70.
  3. Thomas MK, Lloyd-Jones DM, Thadhani RI, Shaw AC, Deraska DJ, Kitch BT et al. Hypovitaminosis D in medical inpatients. N Engl J Med 1998; 338: 777–83.
  4. Chan YL, McKay C, Dye E, Slatopolsky E. The effect of 1,25 dihydroxycholecalciferol on parathyroid hormone secretion by monolayer cultures of bovine parathyroid cells. Calcif Tissue Int 1986; 38: 27–32.
  5. Goltzman D, Miao D, Panda DK, Hendy GN. Effects of calcium and of the Vitamin D system on skeletal and calcium homeostasis: lessons from genetic models. J Steroid Biochem Mol Biol 2004; 89–90: 485–9.
  6. Naveh-Many T, Silver J. Regulation of parathyroid hormone gene expression by hypocalcemia, hypercalcemia, and vitamin D in the rat. J Clin Invest 1990; 86: 1313–9.
  7. Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 2008; 87: 1080–6.
  8. Janssen HC, Samson MM, Verhaar HJ. Vitamin D deficiency, muscle function, and falls in elderly people. Am J Clin Nutr 2002; 75: 611–5. Mosekilde L. Vitamin D and the elderly. Clin Endocrinol (Oxf) 2005; 62: 265–81. Reginster JY. The high prevalence of inadequate serum vitamin D levels and implications for bone health. Curr Med Res Opin 2005; 21: 579–86. Zittermann A. Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr 2003; 89: 552–72.
  9. Bordelon P, Ghetu MV, Langan RC. Recognition and management of vitamin D deficiency. Am Fam Physician 2009; 80: 841–6.
  10. Karadağ AS, Ertuğrul DT, Tutal E, Akın KO. The role of anemia and vitamin D levels in acute and chronic telogen e